FDA inspection
Celltrion Pharm, Inc.: FDA inspection ending Jun 16, 2023
FDA inspection 1209014 · No Action Indicated (NAI) · Cheongju
Key facts
| Inspection ID | 1209014 |
|---|---|
| Firm | Celltrion Pharm, Inc. |
| FEI number | 3012279978 |
| Address | Cheongwon, 2 Sandan-Ro; Ochang-Eup |
| City | Cheongju |
| Fiscal year | 2023 |
| Inspection end date | Jun 16, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data